The chlamydia-positive patients were younger (P<0 001), did not complain of pelvic discomfort or pain (P<0-01), and used oral contraceptives (P<0 001) more frequently than did the controls; intrauterine devices were used more often (P<0-01) by the controls. Increased vaginal discharge was reported significantly more often in chlamydia-positive patients than in the controls (P<0-05). Of 266 women harbouring C trachomatis the organism was still present in 22 (8 3%o) when they were followed up from two to more than eight weeks after finishing treatment with doxycycline.
Introduction
Chlamydia trachomatis and Neisseria gonorrhoeae are the most important aetiological agents of sexually transmitted diseases (STD) in Sweden. The prevalence of genital C trachomatis infection in Swedish women attending STD clinics' 2 and gynaecological clinics for health checks,1 applying for legal abortion,3 seeking contraceptive advice,' and attending gynaecological outpatient clinics with signs of lower genital tract infection (LGTI)4 has varied between 5% and 250/o. Serological studies have indicated that at least half of all cases of acute salpingitis in southern Sweden are associated with chlamydial infection. 56 Oral administration of tetracycline for 7-21 days has proved useful in treating chlamydial cervicitis.4 7 The aims of this study were to determine the prevalence of chlamydial cervicitis in women with patients with gonorrhoea alone and the women in the other three groups (table II) . The patients in groups I and 4 reported itching or burning or both more often than those in group 3 (P = 0-022 and P = 0-038 respectively). The women in group 3 complained of frequency or pain on voiding or both significantly more often than those in groups I and 4 (p = 0 0071 and P = 045 respectively). The patients in group I differed from those in group 4 in several respects: the women in group I had been pregnant significantly less often (P<0 05), complained of pelvic discomfort or pain less often (P<0-01), and had increased vaginal discharge more often (P<0-05) than those in group 4.
Although all the patients studied complained of symptoms that suggested LGTI such an infection was diagnosed in only 221 (78*6%7o), 33 (78*60%o), 13 (76-5%7o), and 100 (68 5 o) women in groups 1, 2, 3, and 4 respectively. The difference between groups I and 4 was significant (P<0 05) Oral contraceptives were used more frequently by the patients in group I than by those in group 4 (P<0001); the opposite was found in the use of intrauterine devices (IUD) (P<0-01) (table II) . There were no differences between the two groups in the use of other contraceptive methods.
AGE-RELATED CORRELATIONS
When patients in the same age group are compared no significant difference was found in the frequency of chlamydial infection between women who had or never had been pregnant. Women in group I under 25 years of age had been treated previously for LGTI significantly (P<0 01) more often than those in group 4 (46%7o and 25 -8%o respectively). In the women aged between 20 and 24 years complaints of increased vaginal discharge were significantly (P<0 05) more common in group 1 (73 6%o) than in group 4 (55%Wo). Pelvic discomfort or pain was significantly (P<0-01) more common in group 4 (83 30o) than in group 1 (48-3bo) in women aged between 25 and 29 years. The comparatively low isolation rate in this study (9-20o) might be due to less strict criteria for the diagnosis of LGTI, so that our series included many women who were not infected. Another explanation for differences in the isolation rate between various series is a difference in the age distribution of the patients studied. Thus, the present as well as earlier studies' 3 show that C trachomatis infection in women with cervicitis occurs more often in younger age groups. Women with chlamydia-associated salpingitis are also significantly younger than patients with non-chlamydial or nongonococcal salpingitis. '5 Of the patients in our study who were subsequently found to have acute salpingitis, 52 (26-50o) of 195 harboured C trachomatis in the cervix. Serological studies suggested, however, that at least twice as many of these cases were associated with a chlamydial infection.5 6 Of the 350 women with symptoms of LGTI and who were culture-positive for C trachomatis, 14-9% had acute salpingitis. The corresponding figure for the 83 women with gonorrhoea was 27 5%o. These figures include the few women who were infected with both organisms.
Women with chlamydial LGTI attending STD clinics have the same symptoms and signs (except for cervical ectopy) as other patients with cervicitis not associated with this organism. 14 In our study increased vaginal discharge was more common in the chlamydia-positive women than in the controls. However, when only the wome!n with clinical LGTI were analysed, no such difference was found. The difference in pelvic discomfort or pain between the chlamydia-positive patients and the controls was significant, whether patients with symptoms or symptoms and signs of LGTI were compared.
Several studies16 17 have shown that women infected with C trachomatis used oral contraceptives more often than did the controls, whereas others'4 18 report no such relationship. In none of these studies, however, was the age distribution of the patients considered. In our study there was no difference in the culture results and the use of oral contraceptives among teenagers, but in women over 20 years of age oral contraceptives were used significantly more often by the chlamydia-positive patients than by the controls.
IUDs were used significantly more often by the controls than by the chlamydia-positive patients in the over-20 age group (regardless of whether or not they had signs of LGTI). All IUDs used by the women in the present study were copper-coated. It and 68%o.10 [20] [21] [22] In women with signs of LGTI, particularly in the younger age groups, chlamydial isolation should be performed, since women with LGTI harbouring chlamydia present with the same symptoms as women in whom LGTI is not associated with 
